Resources from the same session
2714 - Predictive and prognostic value of B-cell gene-expression signatures and B-cell receptor (BCR) repertoire in HER2+ breast cancer: a correlative analysis of the CALGB 40601 clinical trial (Alliance).
Presenter: Aranzazu Fernandez-Martinez
Session: Proffered Paper - Breast cancer, early stage
Resources:
Abstract
Slides
Webcast
4736 - Prognostic value of tumor infiltrating lymphocytes (TILs) in patients with early-stage triple negative breast cancers (TNBC) in the absence of chemotherapy
Presenter: Ji Hyun Park
Session: Proffered Paper - Breast cancer, early stage
Resources:
Abstract
Slides
Webcast
6136 - Clinical Outcomes by Chemotherapy Regimen in Patients with RS 26-100 in TAILORx
Presenter: Joseph Sparano
Session: Proffered Paper - Breast cancer, early stage
Resources:
Abstract
Slides
Webcast
4667 - Peripheral neuropathy (PN), thrombocytopenia (TCP) and central nervous system (CNS) recurrence: an update of the phase III KATHERINE trial of post-neoadjuvant trastuzumab emtansine (T-DM1) or trastuzumab (H) in patients (pts) with residual invasive HER2-positive breast cancer (BC)
Presenter: Michael Untch
Session: Proffered Paper - Breast cancer, early stage
Resources:
Abstract
Slides
Webcast
Proffered Paper - Breast cancer, early stage - Invited Discussant 174O and 175O
Presenter: Christos Sotiriou
Session: Proffered Paper - Breast cancer, early stage
Resources:
Slides
Webcast